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Abstract 
The histone variant 2AX (H2AX) is phosphorylated at Ser139 by the PI3K-like kinase family 
members ATM, ATR and DNA-PK. Genotoxic stress such as tumor radio- and chemotherapy 
is considered to be the main inducer of phosphorylated H2AX (γH2AX) which forms distinct 
foci at sites of DNA damage where DNA repair factors accumulate. γH2AX accumulation 
under severe hypoxic/anoxic (0.02% oxygen) conditions has recently been reported to follow 
replication fork stalling in the absence of detectable DNA damage. In this study, we found 
HIF dependent accumulation of γH2AX in several cancer cell lines and mouse embryonic 
fibroblasts exposed to physiologically relevant chronic hypoxia (0.2% oxygen) which did not 
induce detectable levels of DNA strand breaks. The hypoxic accumulation of γH2AX was 
delayed by RNAi mediated knockdown of HIF-1α or HIF-2α and further decreased when both 
HIF-αs were absent. Conversely, basal phosphorylation of H2AX was increased in cells with 
constitutively stabilized HIF-2α. These results suggest that both HIF-1 and HIF-2 are 
involved in γH2AX accumulation by tumor hypoxia which might increase the cancer cell's 
capacity to repair DNA damage, contributing to tumor therapy resistance. 
Keywords: DNA damage response; oxygen sensing; tumor hypoxia. 
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Introduction: tumor hypoxia and therapy resistance 
Hypoxia is a common feature of solid tumors and develops due to inadequate vascularization, 
tortuous blood vessels and high oxygen consumption. Transient blockage of red blood cell 
flux alternating with rapid alleviation leads to frequent periodical hypoxia/ischemia followed 
by reoxygenation (Yasui et al., 2010). Reoxygenation, most likely mediated by the generation 
of reactive oxygen species (ROS), but not hypoxia can lead to detectable DNA damage 
(Hammond et al., 2003). Hypoxia is strongly associated with malignant progression, 
metastatic outgrowth, genetic instability, resistance to radio-and chemotherapy and overall 
poor patient prognosis in various tumor types. (Brown, 1998; Brown et al., 2004; Pouysségur 
et al., 2006). Therefore, a thorough understanding of the molecular pathways in the hypoxic 
tumor microenvironment is warranted in order to develop new strategies for efficient cancer 
therapy. 
Central to the cellular response to hypoxia is the heterodimeric hypoxia-inducible 
transcription factor HIF, consisting of one of three oxygen-labile α subunits and a common 
constitutive β subunit (Wenger 2002; Schofield et al., 2004;). HIF activates a large number of 
oxygen regulated genes required for the adaptation of normal cells to hypoxia  
(Wenger et al., 2005). In tumors, HIF-1 is responsible for the generation of new blood vessels 
through transcriptional regulation of the vascular endothelial growth factor (VEGF), for pH 
regulation by increasing the expression of carbonic anhydrase (CA) IX, and for the 
aerobically increased glycolytic capacity of cancer cells, also known as Warburg effect 
(Seagroves et al., 2001; Minchenko et al., 2002; Svastova et al., 2004). Furthermore, hypoxic 
tumor cells are able to maintain metabolic functions without adequate oxygen supply via a 
switch to anaerobic fermentation (Pasteur effect) that is facilitated in a HIF-1 dependent 
manner (Schroeder et al., 2005). Therefore, high HIF-1 levels in the hypoxic tumor 
microenvironment is a well established factor for aggressive tumor growth and a negative 
factor for cancer therapy (Ryan et al., 1998; Ryan et al., 2000; Hopfl et al., 2002; Unruh  
et al., 2003). 
Besides tumor hypoxia that leads to HIF-α protein stabilization, the loss of tumor suppressor 
proteins such as pVHL, p53 or PTEN or oncogenes such as v-src can contribute to high HIF-α 
levels in cancer cells (Jiang et al., 1997; Krieg et al., 2000; Ravi et al., 2000; Zundel et al., 
2000). Both HIF-1α and HIF-2α are widely overexpressed in many human cancers and are 
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frequently associated with malignancy and poor prognosis (Birner et al., 2000; Aebersold  
et al., 2001). Furthermore, high HIF-1α protein levels have been shown to correlate with 
incomplete responses to chemotherapy and radiotherapy (Aebersold et al., 2001; Koukourakis 
et al., 2002; Bachtiary et al., 2003; Generali et al., 2006). Hypoxia per se affects radiation 
sensitivity since the radiation induced DNA damage is dependent on oxygen  
(Gray et al., 1953). In addition, decreased cell proliferation and lower drug concentrations in 
the hypoxic tumor areas contribute to the resistance to chemotherapy. However, the 
underlying molecular mechanisms causing therapy resistance of hypoxic tumor cells are 
incompletely understood, but it is likely that HIF downstream targets are directly involved in 
these processes. 
Targeting HIF to improve cancer therapy 
HIF-1 dependent hypoxic induction of the multidrug resistance MDR1 gene was one of the 
first described molecular mechanism explaining the involvement of HIF-1 in chemotherapy 
resistance in various tumor cells, including breast carcinoma, gastric cancer, colon cancer and 
glioma (Comerford et al., 2002; Wartenberg et al., 2003; Zhou et al., 2005; Nardinocchi  
et al., 2009). Hypoxically dysregulated apoptosis in response to chemotherapy might be 
another explanation (Erler et al., 2004; Sermeus et al., 2008). The role of HIF-1 in the 
regulation of apoptosis is very complex and context specific. The involvement of HIF-1 in 
apoptosis in certain cell types cannot be generalized since cells do not undergo apoptosis 
under degrees of hypoxia sufficient for HIF-1 induction (Wenger et al., 1998). In primary 
cells, hypoxia typically leads to cell cycle arrest and HIF-1 dependent apoptosis in case of 
more severe conditions (Greijer et al., 2004). However, HIF-1 functions as a robust 
suppressor of apoptosis in most transformed cells. We previously reported that transformed 
mouse embryonic fibroblasts (MEFs) were more sensitive to chemotherapy as well as to 
radiotherapy in the absence of HIF-1α due to an impaired DNA double-strand break (DSB) 
repair capacity (Wirthner et al., 2008). The underlying molecular mechanism involve 
markedly reduced expression of DNA-PKcs, Ku80 and Ku70, three members of the  
DNA-dependent protein kinases (DNA-PK), in HIF-1α deficient MEFs. Our data were 
supported by a large number of studies that demonstrate reversal of radio- and 
chemoresistance by targeting HIF-1α in various tumor types (Zhang et al., 2004; Moeller  
et al., 2005; Williams et al., 2005; Brown et al., 2006; Li et al., 2006; Li et al., 2006; Song  
et al., 2006; Sasabe et al., 2007). For example, Li et al. showed that knockdown of HIF-1α in 
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breast carcinoma cells repressed G0/G1 phase accumulation and relieved S phase block, 
thereby increasing sensitivity to chemotherapy and attenuating tumor growth (Li et al., 2006). 
Functional interference with HIF-1α in various tumor cells has been shown to result in 
enhanced cell death upon treatment with chemotherapeutic agents (Ricker et al., 2004; Peng 
et al., 2006; Hao et al., 2008; Sermeus et al., 2008; Flamant et al., 2010). On the other hand, 
experimentally increasing HIF-1α enhanced therapy resistance (Ji et al., 2006; Martinive  
et al., 2006). Of note, HIF-1 in germ cells of Ceanorhabditis elegans has recently been 
reported to antagonize p53-mediated apoptosis upon to DNA damage (Sendoel et al., 2010).  
The induction of DNA damage by cytotoxic agents has proved to be an effective strategy for 
cancer therapy (Einhorn, 2002; Agarwal et al., 2003; Pires et al., 2012). Mutations in DNA 
damage response (DDR) genes can lead to increased frequency and incorrect DNA damage 
repair, thereby contributing to genomic instability characteristic for cancer cells  
(Bolderson et al., 2009). Because HIF-1 mediated therapy resistance was only observed when 
DSB but not single-strand break (SSB) inducing agents were applied, we suspected that HIF-1 
might be involved specifically in DNA-DSB repair (Unruh et al., 2003).  
The DNA damage response in hypoxia 
Upon DNA damage, histone H2AX is rapidly phosphorylated at Serine 139 by ataxia 
teleangiectasia mutated (ATM) kinase, ATM- and Rad3-related (ATR) kinase and DNA-PK 
(Fernandez-Capetillo et al., 2004; Zhang et al., 2006; Hurley et al., 2007). Previous studies 
suggested that severe hypoxia can elicit a DNA damage-like response, implying the activation 
of the ATR and ATM pathways and subsequent phosphorylation of H2AX  
(Hammond et al., 2003; Bencokova et al., 2009). More recently, Economopoulou et al. 
identified a novel role for histone H2AX in hypoxia triggered angiogenesis  
(Economopoulou et al., 2009). Replication specific γH2AX was found to be induced in an 
ATR dependent manner in endothelial cells exposed to milder hypoxia (1% O2). Whether HIF 
is involved in the hypoxic induction of γH2AX has not been analyzed so far. Therefore, we 
investigated a potential role for HIF-1 and HIF-2 in the phosphorylation of H2AX under 
chronically hypoxic (0.2% O2) conditions. Hypoxic γH2AX induction was observed in a 
range of cancer cell lines, was delayed in HIF-1α deficient MEFs and after HIF-1α and  
HIF-2α knockdown in Hek293 cells, and was further decreased when both HIFs were 
downregulated. Vice versa, in 786-0 cells, devoid of pVHL and constitutively expressing 
HIF-2α, H2AX phosphorylation was increased, and could be reversed by pVHL 
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reconstitution. These results suggest that HIF plays a crucial role in the DNA damage 
response under hypoxia. 
Results 
γH2AX accumulation in chronic hypoxia 
Hammond et al. previously reported that severe hypoxia/anoxia (0.02% O2) leads to ATR 
dependent γH2AX accumulation which was attributed to S-phase arrest  
(Hammond et al., 2002; Hammond et al., 2003). Because an atmospheric oxygen 
concentration of 0.02% O2 results in a tissue partial pressure of oxygen which is most likely 
below the threshold for mitochondrial respiration, we investigated γH2AX induction under 
physiologically relevant hypoxic conditions. To ensure unimpaired mitochondrial respiration, 
an atmospheric oxygen concentration of 0.2% O2 was chosen, corresponding to an oxygen 
partial pressure of approx. 1.5 mmHg. Ischemia-like conditions and reoxygenation induced 
ROS formation followed by DNA damage was prevented by replacing the cell culture 
medium every 24 hours with pre-equilibrated medium and by harvesting the cells inside of a 
hypoxic workstation. Several cancer cell lines were exposed to 0.2% O2 for 3 to 72 hours, 
followed by analysis of H2AX Ser139 phosphorylation by immunoblotting. As shown in 
Figure 1A, γH2AX accumulated time-dependently in all six cell lines and reached maximal 
induction after 24 - 48 hours of hypoxic exposure, depending on the cell line. Hypoxic 
γH2AX induction in wild-type HEK293 cells with normal p53 was similar to SV40 large T 
antigen immortalized HEK293T cells, suggesting that p53 is not involved in hypoxic H2AX 
phosphorylation. Only wild-type HEK293 cells were used for subsequent experiments.  
We next compared γH2AX accumulation in hypoxia with the effects of the topoisomerase II 
inhibitor and DSB inducing agent etoposide (Burden et al., 1998). γH2AX slowly 
accumulated in hypoxia with a maximum after 48 - 72 hours and declined after 96 hours 
(Figure 1B). One hour of etoposide treatment with concentrations from 0.25 - 8 μM resulted 
in a similar, dose-dependent increase in γH2AX levels. Total H2AX levels remained 
unaffected after both hypoxic exposure and etoposide treatment (Figure 1B). 
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Hypoxic γH2AX accumulation is HIF dependent 
The involvement of HIF in hypoxic H2AX phosphorylation was investigated by shRNA 
mediated stable knockdown of HIF-1α and/or HIF-2α in HEK293 cells. Hypoxic γH2AX 
accumulation was delayed after shRNA mediated knockdown of either HIF-1α or HIF-2α, 
with maximal levels only after 72 hours compared to 24 - 48 hours in the parental control 
(Figure 2A). Total H2AX remained unaffected (Figure 2A). Concomitant HIF-1α and HIF-2α 
double knockdown substantially decreased hypoxic phosphorylation ofα H2AX at all time 
points (Figure 2B). 
To corroborate these findings, two different MEF cell lines derived from two different HIF-1α 
knockout mouse strains were analyzed. These cell lines were either only immortalized by 
SV40 large T (MEF-Hif1a-/-T) or immortalized and transformed by H-ras (MEF-Hif1a-/-rT), 
respectively (Feldser et al., 1999; Ryan et al., 2000). Importantly, these MEF cell lines were 
shown to lack functional HIF-2α protein (Park et al., 2003). Confirming the results obtained 
with HEK293 cells, γH2AX levels in wt MEFs accumulated after 24 hours exposure to 0.2% 
O2, but were strongly impaired in MEFs devoid of HIF-1α. Total histone levels remained 
unaffected as shown by Ponceau S staining of the extracted histone fraction (Figure 2C). We 
previously reported increased susceptibility to DNA damage with enhanced phosphorylation 
of H2AX in MEF-Hif1a-/-rT upon low dose (0.5 - 4 μM) etoposide treatment  
(Wirthner et al., 2008). However, the HIF dependent difference of γH2AX levels decreased 
with higher doses of etoposide and was invisible upon treatment with 8 μM  
(Wirthner et al., 2008). In line with these findings, no HIF-1α dependent changes in γH2AX 
induction could be observed after high dose (8 μM) etoposide treatment which resulted in 
γH2AX levels that were only slightly higher than the γH2AX levels in HIF-1α positive MEFs 
after 24 hours of hypoxia (Figure 2C).  
To further confirm the role of HIF in hypoxic γH2AX accumulation, parental and  
HIF-1α/HIF-2α double knockdown HEK293 cells were grown under 20% or 0.2% O2 
conditions for up to 72 hours before γH2AX levels were quantified by FACS analysis. While 
88% of parental cells were strongly γH2AX positive after 48 and 72 hours of hypoxia, only  
20 - 24% of the HIF-1α/HIF-2α double knockdown HEKs showed similarly elevated γH2AX 
staining (Figure 2D). 
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Finally, VHL-deficient 786-0 cells, containing constitutively stabilized HIF-2α  
(Maxwell et al., 1999), and reconstituted 786-0-pVHL cells were cultured under 20% or 0.2% 
O2 conditions for 4 - 72 hours and analyzed by immunoblotting. In line with our findings 
above, both basal and hypoxic levels of γH2AX were substantially higher in 786-0 cells 
compared to 786-0-pVHL cells (Figure 2E). 
Hypoxic γH2AX accumulation is independent of DNA-DSB formation 
Hypoxia has previously been suggested to induce genetic instability, associated with 
increased HIF-1α levels (Bristow et al., 2008). However, the previously published lack of 
detectable DNA damage at 0.02% O2 suggests that hypoxic γH2AX accumulation might be 
partially or fully independent of DNA-DSB formation (Hammond et al., 2003). To directly 
assess DNA-SSB and DNA-DSB formation under 0.2% O2 conditions, we performed alkaline 
single-cell electrophoresis (comet assays) in wild-type and HIF-1α deficient MEFs and 
concomitantly determined γH2AX protein levels by immunoblotting. As shown in Figure 3A, 
emergence of DNA-DSB induced by 1 μM etoposide could be visualized reliably by  
"comet halo" formation. Quantification of the median of the tail moment demonstrated a 
significant (p < 0.0001) 4-fold increase following treatment with 1 μM etoposide for 1 hour 
but not after up to 24 hours of 0.2% O2 (Figure 3B, upper panel). In contrast, γH2AX levels in 
HIF-1α wild-type MEFs were even higher after 12 and 24 hours of hypoxia than following 
treatment with 1 μM etoposide (Figure 3B, lower panel). Taken together, these data suggest 
that DNA-DSB is not a major determinant of hypoxic γH2AX induction. 
Discussion 
Hypoxic regions in solid tumors result from an imbalance between cellular oxygen 
consumption and oxygen delivery as a consequence of inefficient tumor vasculature and 
limited oxygen diffusion (Chitneni et al., 2011). Rapid and frequent variations in red blood 
cell flux cause temporal and spatial variations in the degree of hypoxia within the same tumor. 
We found that chronic hypoxia triggers the phosphorylation of the histone variant 2AX in a 
HIF dependent manner. In line with a previous report (Hammond et al., 2003), we showed 
that γH2AX levels after chronic hypoxia were comparable with etoposide treatment. Hypoxia 
(0.2% O2) did not lead to detectable DNA damage when analyzed by alkaline single cell 
electrophoresis. Furthermore, proliferation and cell viability were not altered, even after long 
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term (3 days) hypoxic exposure (data not shown). However, conditions close to anoxia have 
been reported to have direct cytotoxic effects and elicit apoptosis (Papandreou et al., 2005). In 
line with our previous findings (Wirthner et al., 2008), 53BP1 dose-dependently accumulated 
in distinct nuclear foci upon treatment with etoposide and partially overlapped with γH2AX 
staining (data not shown). These foci are most likely sites of DNA-DSBs. In contrast, in 
chronic hypoxia γH2AX did not accumulate in nuclear foci but showed a more diffuse pattern 
throughout the nucleus (data not shown). A similar granular γH2AX and ATM  
phospho-S1981 staining has been reported previously to occur in response to severe hypoxia 
(0.02% O2) (Hammond et al., 2003; Bencokova et al., 2009). Hammond et al. found that 
severe hypoxia leads to replication fork stalling and ATR dependent γH2AX accumulation 
during S-phase (Hammond et al., 2002; Hammond et al., 2003). Moreover, diffuse and pan-
nuclear γH2AX staining has been found to occur upon non-ionizing UV-C irradiation, 
independent of DNA-DSBs (Marti et al., 2006). Infection with inactivated adeno-associated 
virus has been shown to lead to replication fork stalling and a diffuse γH2AX nuclear staining 
which was essential for subsequent cell cycle arrest in the absence of DNA damage  
(Fragkos et al., 2009). However, the mechanism behind this diffuse γH2AX distribution 
pattern as well as its functional relevance are currently unknown. 
DNA-DSBs are serious lesions that can lead to genomic instability if improperly repaired, or 
ultimately to cell death if the repair machinery is saturated. It is essential that the cell closely 
monitors such stress conditions and initiates signals for an adequate response. 
Phosphorylation of H2AX on serine 139 is established as a sensitive marker for DNA-DSBs 
(Bonner et al., 2008). γH2AX is regarded as a key component for DNA repair, even though it 
seems dispensable for the initial recognition of DNA-DSBs and H2AX-deficient mice are 
viable (Celeste et al., 2002; Celeste et al., 2003).  
The physiologic relevance of hypoxia induced γH2AX is poorly understood. A recent report 
showed that hypoxia triggered neovascularization required endothelial H2AX and γH2AX 
was induced in an ATR dependent manner in moderate hypoxia due to replicative stress 
(Economopoulou et al., 2009). Genetic inactivation of H2AX was sufficient to suppress 
tumor angiogenesis and growth in xenograft models. However, this study did not address the 
question whether HIFs are involved in this effect. In the present work, we were able to show 
that HIF is an integral factor required for efficient phosphorylation of H2AX under 
physiologically relevant hypoxic conditions, and that hypoxic γH2AX induction was delayed 
in the absence of HIF-α. We previously reported that DNA-PK expression was strongly 
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reduced by the absence of HIF-1α under both normoxic and hypoxic conditions  
(Wirthner et al., 2008), raising the possibility that DNA-PK might be the responsible kinase 
for H2AX phosporylation in chronic hypoxia. In line with this hypothesis, accumulation of 
DNA-PKcs, Ku70 and Ku80 following hypoxia and iron chelation has been demonstrated in a 
number of different cell lines (Ginis, et al., 2000; Lynch, et al., 2001; Um, et al., 2004; 
Bouquet et al., 2011). DNA-PK has been shown to phosphorylate H2AX in different cell lines 
and in vivo in response to DNA damage (Stiff et al., 2004; Koike et al., 2008; An et al., 
2010), under hypertonic conditions (Reitsema et al., 2005) and during apoptotic DNA 
fragmentation (Mukherjee et al., 2006). Of note, the hypoxic DNA-PK activation resulted in 
increased HIF dependent gene expression (Bouquet et al., 2011). These data suggest that 
DNA-PK might be both upstream and downstream of HIF.  
In summary, our data indicate a novel DNA-DSB independent mechanism by which HIF 
downstream effectors might be involved in histone H2AX phosphorylation during hypoxia 
and hence could contribute to therapy resistance of hypoxic cancer cells.  
Materials and methods 
Cell culture and lentiviral transduction 
All cell lines were cultured in high glucose Dulbecco's modified Eagle's medium  
(DMEM; Sigma, Buchs, Switzerland) as described previously (Stiehl et al., 2006). For 
chronic hypoxic exposure, cells were grown in a gas-controlled glove box to handle the cells 
under constant oxygen (InvivO2 400, Ruskinn Technologies, Leeds, UK). Before medium 
change, all reagents were pre-equilibrated to the 0.2% O2 containing gas mixture inside the 
glove box. Cell number, size and viability were determined by trypan blue exclusion using an 
automatic cell analyzer (Vi-Cell, Beckman-Coulter, Nyon, Switzerland). Stable knockdown of 
HIF-1α and HIF-2α in HEK293 cells by RNA interference was achieved by lentiviral 
transduction of short hairpin (shRNA) constructs. Viral particles were produced in HEK293T 
human enbryonic kidney cells using the ViraPower lentiviral expression system according to 
the manufacturer's protocol (Invitrogen, Basel, Switzerland) as described previously  
(Stiehl et al., 2012). 
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Immunoblot analysis  
Histone immunoblotting was performed as described previously (Wirthner et al., 2008). 
Primary antibodies used were: γH2AX (Millipore, Zug, Switzerland); total H2AX (Millipore), 
β-actin (Sigma, Buchs, Switzerland). Horseraddish peroxidase coupled secondary anti-mouse 
and anti-rabbit antibodies were purchased from Pierce (Lausanne, Switzerland). 
Chemiluminescence detection was performed using Supersignal West Dura (Pierce) and 
signals were recorded and quantified using a charge-coupled device camera (Lightimager 
LAS-4000mini, Fujufilm, Dielsdorf, Switzerland). Extracted histones were stained with 
Ponceau S (Sigma). 
Flow cytometry 
Single cell suspensions were incubated with an antibody against γH2AX and propidium 
iodide (PI) according to manufacturer's instructions. Stained cells were analyzed with a 
FACSCanto II utilizing FACSDiva software (BD Biosiences, Allschwil, Switzerland). 
Single cell electrophoresis (comet assays) 
Alkaline single cell electrophoresis was performed as described before (Wirthner et al., 2008). 
Briefly, MEFs were mixed with 0.5% low melting-point agarose (Sigma), solidified on 
microscopy slides, and lysed with 1% Triton-X100, 2.5 M NaCl, 100 mM EDTA, 10 mM 
Tris-HCl (pH 10.0) for 1 hour at 4°C in the dark. Horizontal electrophoresis (~0.74 V/cm; 300 
mA) was performed in 300 mM NaOH, 1 mM EDTA for 30 minutes. Following SYBR green 
(Invitrogen) staining, DNA migration was visualized by fluorescence microscopy and the tail 
moment (% DNA in tail multiplied by tail length) was calculated from >150 cells per 
condition using the CometScore software package (TriTek, Sumerduck, VA, USA). 
Quantification of the median tail moments is shown as mean values ± standard error of the 
mean (SEM). Statistical analysis was performed applying two-tailed Student's t-test using 
GraphPad Prism version 4.0 (GraphPad Software, Ja Jolla, California, USA).  
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Figure 
 
Figure 1 Phosphorylation of H2AX in chronic hypoxia. 
(A) The indicated cancer cell lines were cultured under 20% or 0.2% O2 conditions for up to 
72 hours and γH2AX protein levels were analyzed by immunblotting. β-actin served as a 
control for equal loading and blotting. (B) HEK293 cells were exposed to 20% or 0.2% O2 for 
up to 96 hours or to various etoposide concentrations up to 8 μM for one hour in normoxia. 
Phosphorylated and total H2AX were analyzed by immunoblotting. 
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Figure 2 HIFs are required for hypoxic γH2AX accumulation. 
(A, B) Parental, shRNA-mediated HIF-1α or HIF-2α knockdown (shHIF1A or shHIF2A, 
respectively) or HIF-1α/HIF-2α double knockdown (shH1A/H2A) HEK293 cells were grown 
under 20% or 0.2% O2 conditions for the indicated time points. Phosphorylated and total 
H2AX was analyzed by immunblotting and β-actin served as a control for equal loading and 
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blotting. (C) MEF-Hif1a+/+rT, MEF-Hif1a-/-rT, MEF-Hif1a+/+T, MEF-Hif1a-/-T were exposed 
to 20% or 0.2% O2 for 4 or 24 hours, or treated with 8 μM etoposide for 1 hour. Ponceau S 
staining was used as a control for equal extraction and loading of histones. (D) Parental and 
HIF-1α/HIF-2α double knockdown (shH1A/H2A) HEK293 cells were grown under 20% or 
0.2% O2 conditions for the time points indicated before γH2AX levels were analyzed by 
FACS. γH2AX positive cells were gated as indicated by the rectangles and quantified relative 
to the total cell number. (E) 768-0 and 786-0-pVHL cells were grown under 20% or 0.2 % O2 
conditions for 24 to 72 hours and γH2AX and β-actin protein levels were analyzed by 
immunoblotting. 
 
Figure 3 Hypoxia does not induce detectable DNA strand breaks. 
(A) Representative example of a comet assay. DNA fragmentation in wildtype MEFs was 
induced by exposure to 1 μM etoposide for 1 hour. DNA was stained with SYBR green and 
all images were acquired with fixed exposure times. (B) DNA fragmentation was quantified 
by determining the median tail moment of at least 150 comets per condition using 
CometScore software. Data are shown was mean values ± SEM. 
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